Pancreatic cancer has a low survival rate and is usually found too late — this new test may help change that Researchers have ...
A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...
A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...
Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...
Thanks to decades of sustained, predictable federal investments and increases in pancreatic cancer research, the research ...
In patients with pancreatic ductal adenocarcinoma, KRAS G12D and G12V mutations hare associated with worse patient outcomes, ...
A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study ...
A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.
Pancreatic cancer is the third leading cause of cancer-related deaths in the country. The Ramone Foundation is hosting a ...
Pancreatic cancer, representing 3% of all cancer cases and 7% of cancer-related deaths in the US, is a serious health concern ...